Inferior vena cava

Global Vena Cava Filters Market (2021 to 2026) - Featuring ALN International, Argon Medical Devices and Medtronic Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, August 27, 2021
Medical Devices, Health, Thrombosis, DVT, Laboratory, Catheter, Incidence, Inferior vena cava, First Nations in Ontario, Coronavirus, Inferior vena cava filter, World Health Organization, Person, Cava, Death, World, Heart, Awareness, Lists of countries and territories, COVID-19, Patient, Degenerative disease, Pulmonary embolism, Recurrence, Venae cavae, United Nations, Embolism, Pharmaceutical industry

The vena cava filters are either permanently placed or are retrievable, depending on their use to prevent the recurrence of pulmonary embolism.

Key Points: 
  • The vena cava filters are either permanently placed or are retrievable, depending on their use to prevent the recurrence of pulmonary embolism.
  • The increasing incidence of such diseases will support the market growth of the vena cava filters market as more patients will require it for their treatment.
  • The vena cava filters treatment is a costly treatment which makes it unaffordable for a majority of patients.
  • The Covid-19 pandemic moderately impacted the global vena cava filters market as due to the nationwide lockdown restrictions; many patients deferred their ongoing treatments to avoid public places which hampered the market growth.

Philips receives FDA Breakthrough Device Designation for laser-assisted IVC filter removal device

Retrieved on: 
Wednesday, July 21, 2021
Medical specialties, Angiology, Inferior vena cava filter, Interventional radiology, Clinical medicine, Inferior vena cava, IVC, Deep vein thrombosis, Filtration, Filter, Electronic filter, Water filter

Limited options exist for embedded IVC filter removal, and independent studies indicate high success rates using a Philips excimer laser sheath

Key Points: 
  • Limited options exist for embedded IVC filter removal, and independent studies indicate high success rates using a Philips excimer laser sheath
    Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the FDA has granted Breakthrough Device Designation (BDD) for a laser-assisted inferior vena cava (IVC) filter removal device.
  • The proposed device is intended for ablating tissue to remove an IVC filter when previous methods of removal have failed.
  • Other identified long-term risks associated with IVC filters include lower limb deep vein thrombosis and IVC occlusion.
  • The failure rate for IVC filter removal is high and limited options for removal exist if the filter has become difficult to remove.

Study Comparing Two Noninvasive Indicators of Fluid Responsiveness on Mechanically Ventilated Patients Finds Masimo PVi® Effective and Advantageous

Retrieved on: 
Monday, November 30, 2020
Cardiology, Biotechnology, Health, General Health, Other Science, Medical devices, Research, Infectious diseases, Hospitals, Surgery, Science, Masimo, PVI, Health care, Inferior vena cava, Venae cavae, Patient safety, California, Health

The accuracy of PVi in predicting fluid responsiveness is variable and influenced by numerous patient, procedure, and device-related factors.

Key Points: 
  • The accuracy of PVi in predicting fluid responsiveness is variable and influenced by numerous patient, procedure, and device-related factors.
  • Fluid management decisions should be based on a complete assessment of the patients condition and should not be based solely on PVi.
  • Masimo hospital automation and connectivity solutions are centered around the Masimo Hospital Automation platform, and include Iris Gateway, Patient SafetyNet, Replica, Halo ION, UniView, UniView: 60, and Masimo SafetyNet.
  • Prediction of fluid responsiveness in mechanically ventilated patients in surgical intensive care unit by pleth variability index and inferior vena cava diameter.

Global Inferior Vena Cava Filters Market (2020 to 2024) - Featuring B Braun, Boston Scientific and Red Medical Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, September 28, 2020
Medical devices, Health, Medical specialties, Inferior vena cava filter, Interventional radiology, Anatomy, Clinical medicine, Venae cavae, Inferior vena cava, Vena

The "Global Inferior Vena Cava Filters Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Inferior Vena Cava Filters Market" report has been added to ResearchAndMarkets.com's offering.
  • This report was developed using extensive primary and secondary research by the publisher's analysts.
  • Data from proprietary databases, proprietary market reports, company reports, import/export databases, and secondary data sources on medical device markets were used to develop estimates of 2019 worldwide market size by product segment, ASPs, sales, and market share for the top suppliers by product segment.
  • Devices in this global market analysis include Vena Cava Filters.

Worldwide Peripheral Vascular Devices Industry to 2025 - Featuring Medtronic, Boston Scientific & Abbott Laboratories Among Others

Retrieved on: 
Tuesday, September 15, 2020
Medical specialties, Interventional radiology, Medicine, Angiology, Endovascular aneurysm repair, Stent, Inferior vena cava filter, Aneurysm, Inferior vena cava, Vascular snare

9 Endovascular Aneurysm Repair Stent Grafts Market, by Type

Key Points: 

9 Endovascular Aneurysm Repair Stent Grafts Market, by Type
10 Inferior Vena Cava Filters Market, by Type
11 Plaque Modification Devices Market, by Type
12 Hemodynamic Flow Alteration Devices Market, by Type
13 Other Peripheral Vascular Devices Market, by Type

FDA Grants the Doraya AHF Catheter Breakthrough Designation

Retrieved on: 
Tuesday, July 14, 2020
Medical specialties, Medicine, Inferior vena cava, Renal vein, Venae cavae, Interventional radiology

NETANYA, Israel, July 14, 2020 /PRNewswire/ -- Revamp Medical, a medical device company developing a percutaneous device for the treatment of acute heart failure (AHF), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the Doraya device.

Key Points: 
  • NETANYA, Israel, July 14, 2020 /PRNewswire/ -- Revamp Medical, a medical device company developing a percutaneous device for the treatment of acute heart failure (AHF), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the Doraya device.
  • The Doraya is a temporary catheter, placed in the Inferior Vena Cava below the renal veins, applying partial adjustable flow for up to 12 hours.
  • The Doraya is currently being evaluated in a First in Human clinical study in Europe, aiming to improve clinical outcomes of AHF patients with low response to diuretic therapy.
  • "As we begin to accelerate our clinical development program in the US, we plan to leverage the benefits of FDA Breakthrough Device Designation."

Global Inferior Vena Cava (IVC) Filter Market (2020 to 2025) - Outlook and Forecast

Retrieved on: 
Thursday, June 4, 2020
Angiology, Cardiovascular system, Medical specialties, Inferior vena cava filter, Interventional radiology, Inferior vena cava, IVC, Venae cavae, Agenesis of the vena cava

DUBLIN, June 4, 2020 /PRNewswire/ -- The "Inferior Vena Cava (IVC) Filter Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, June 4, 2020 /PRNewswire/ -- The "Inferior Vena Cava (IVC) Filter Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • The inferior vena cava filter market is expected to grow at a CAGR of over 10% during the period 2019-2025.
  • The study considers the present scenario of the inferior vena cava filters market and its market dynamics for the period 2019-2025.
  • The global inferior vena cava filter market is to grow steadily during the forecast period.

Insights on the Global Inferior Vena Cava Filter Industry to 2025 - Key Drivers, Trends and Restraints - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 4, 2020
Medical devices, Health, Angiology, Medical specialties, Cardiovascular system, Inferior vena cava filter, Interventional radiology, Inferior vena cava, IVC, Venae cavae, Agenesis of the vena cava

The "Inferior Vena Cava (IVC) Filter Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Inferior Vena Cava (IVC) Filter Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • The inferior vena cava filter market is expected to grow at a CAGR of over 10% during the period 2019-2025.
  • The global inferior vena cava filter market is to grow steadily during the forecast period.
  • Japan, Australia, and South Korea are the major revenue contributors to the inferior vena cava filter market.

Inferior Vena Cava (IVC) Filter Market Size to Reach Revenues Over $1 Billion by 2025 - Arizton

Retrieved on: 
Wednesday, June 3, 2020
Angiology, Cardiovascular system, Medical specialties, Inferior vena cava filter, Interventional radiology, Inferior vena cava, IVC, Venae cavae

CHICAGO, June 3, 2020 /PRNewswire/ -- The inferior vena cava (IVC) filter market is expected to grow at a CAGR of over 10% during the period 20192025.

Key Points: 
  • CHICAGO, June 3, 2020 /PRNewswire/ -- The inferior vena cava (IVC) filter market is expected to grow at a CAGR of over 10% during the period 20192025.
  • The study offers both the demand and supply aspect of the market.
  • It profiles and examines leading companies and other prominent companies operating in the market.
  • The global inferior vena cava filter market is to grow steadily during the forecast period.

Argon Medical Announces the Commercial Launch of Two Inferior Vena Cava Filter Retrieval Kits

Retrieved on: 
Wednesday, January 22, 2020
Medicine, Medical specialties, Interventional radiology, Clinical medicine, Inferior vena cava filter, Percutaneous, Vascular surgery, Inferior vena cava, Radiology, IVC, International Video Corporation, Interventional oncology

FRISCO, Texas, Jan. 22, 2020 /PRNewswire/ --Argon Medical Devices, Inc. announced today the commercial launch of Single-Loop and Triple-Loop Retrieval Kits for sale in the U.S.

Key Points: 
  • FRISCO, Texas, Jan. 22, 2020 /PRNewswire/ --Argon Medical Devices, Inc. announced today the commercial launch of Single-Loop and Triple-Loop Retrieval Kits for sale in the U.S.
  • The Single-Loop and Triple-Loop Retrieval Kits are intended for percutaneous removal of retrievable inferior vena cava (IVC) filters that are no longer medically required, via a jugular approach.
  • "We are excited to improve the IVC filter retrieval options available to our customers with the introduction of these new products," said George A. Leondis, President and CEO of Argon Medical Devices, Inc. "Our Single-Loop and Triple-Loop Retrieval Kits are the only two kits cleared by the FDA for removing any retrievable IVC filter from a jugular approach.
  • Argon Medical Devices, Inc., based inFrisco, TX, is a global manufacturer of specialty medical devices used in interventional procedures.Argon offers a broad line of disposable medical devices for Interventional Radiology, Interventional Oncology and Vascular Surgery.